- Home
- POST vs AXSM Comparison
POST vs AXSM Comparison
Compare POST & AXSM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- POST
- AXSM
- Stock Information
- Founded
- POST 1895
- AXSM 2012
- Country
- POST United States
- AXSM United States
- Employees
- POST N/A
- AXSM N/A
- Industry
- POST Packaged Foods
- AXSM Biotechnology: Pharmaceutical Preparations
- Sector
- POST Consumer Staples
- AXSM Health Care
- Exchange
- POST Nasdaq
- AXSM Nasdaq
- Market Cap
- POST 6.1B
- AXSM 5.1B
- IPO Year
- POST N/A
- AXSM 2015
- Fundamental
- Price
- POST $112.46
- AXSM $100.69
- Analyst Decision
- POST Buy
- AXSM Strong Buy
- Analyst Count
- POST 6
- AXSM 16
- Target Price
- POST $130.50
- AXSM $170.50
- AVG Volume (30 Days)
- POST 513.5K
- AXSM 627.1K
- Earning Date
- POST 07-31-2025
- AXSM 08-04-2025
- Dividend Yield
- POST N/A
- AXSM N/A
- EPS Growth
- POST 8.42
- AXSM N/A
- EPS
- POST 5.65
- AXSM N/A
- Revenue
- POST $7,884,600,000.00
- AXSM $432,157,000.00
- Revenue This Year
- POST $2.63
- AXSM $62.84
- Revenue Next Year
- POST $4.32
- AXSM $60.02
- P/E Ratio
- POST $19.97
- AXSM N/A
- Revenue Growth
- POST 1.48
- AXSM 72.16
- 52 Week Low
- POST $101.51
- AXSM $72.02
- 52 Week High
- POST $125.84
- AXSM $139.13
- Technical
- Relative Strength Index (RSI)
- POST 54.56
- AXSM 37.30
- Support Level
- POST $108.61
- AXSM $99.39
- Resistance Level
- POST $114.71
- AXSM $112.98
- Average True Range (ATR)
- POST 1.58
- AXSM 3.33
- MACD
- POST 0.40
- AXSM -0.76
- Stochastic Oscillator
- POST 63.88
- AXSM 9.35
About POST Post Holdings Inc.
Post Holdings Inc is an consumer packaged goods holding company. It operates in Post Consumer Brands which Includes branded and private label ready-to-eat cereals, Weetabix Includes the businesses of Weetabix Limited, which Post acquired in July 2017 and which produces and distributes branded and private label RTE cereal, hot cereals and other cereal-based food products, Foodservice which Includes egg and potato products in the foodservice and food ingredient channels from the businesses of MFI Holding Corporation, lastly Refrigerated Retail segment Provides refrigerated retail products, inclusive of side dishes, eggs and egg products, sausage, cheese and other dairy and refrigerated products.
About AXSM Axsome Therapeutics Inc.
Axsome Therapeutics Inc is a clinical-stage biopharmaceutical company. It is engaged in developing novel therapies for the management of the central nervous system, or CNS, disorders for which there are limited treatment options. Its pipeline products includes AXS-05, AXS-07, AXS-12, and AXS-14. It manages its business as one operating segment and reporting unit, which is the business of developing and delivering novel therapies for the management of CNS disorders.